Microtissue-encapsulating devices for hypoxia reduction of cellular therapeutics in diabetes treatment
Transplantation of encapsulated islets devoid of immunosuppressants is a potential approach to revive euglycemia in insulin-dependent diabetic patients. However, poor cellular viability impedes the translation of this approach into a clinical treatment due to low oxygen tension at the transplantatio...
Main Author: | Chen, Yang |
---|---|
Other Authors: | Dang Thuy Tram |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/154404 |
Similar Items
Similar Items
-
Identification of hypoxia biomarkers in insulin-secreting microtissues for diabetes therapy
by: Cheng, Trina Shinn Yinn
Published: (2024) -
Waffle-inspired hydrogel-based macrodevice for spatially controlled distribution of encapsulated therapeutic microtissues and pro-angiogenic endothelial cells
by: Pham, Chi H. L., et al.
Published: (2023) -
In-vitro characterization of microencapsulated microtissue viability
by: Chua, Yu Qing
Published: (2023) -
A microfluidic platform to develop a complex organotypic microtissue
by: Lu, Xiao Guang
Published: (2015) -
Non-invasive detection of cellular bioelectricity based on carbon nanotube devices for high-throughput drug screening
by: Pui, Tze Sian, et al.
Published: (2012)